Interactions between glioblastoma and myeloid cells

Area of Science:

• Neuro-oncology
• Immunology
• Cancer Biology

Background:

• Glioblastoma (GBM) is an aggressive brain tumor with significant heterogeneity, posing treatment challenges.
• The tumor microenvironment (TME) of GBM involves complex interactions, including myeloid cells (MCs), T cells, and NK cells.
• Myeloid-derived suppressor cells (MDSCs) within the TME can suppress anti-tumor immune responses, impacting immunotherapy efficacy.

Purpose of the Study:

• To review the critical role of myeloid cells in Glioblastoma (GBM) pathogenesis.
• To explore the dynamic interactions between GBM and its microenvironment, focusing on myeloid cell involvement.
• To provide insights into novel targeted and immunotherapeutic strategies for GBM treatment.

Main Methods:

• Literature review focusing on studies investigating myeloid cell functions in GBM.
• Analysis of the interplay between GBM cells and various myeloid cell populations (neutrophils, MDSCs, microglia, macrophages).
• Examination of how these interactions influence tumor progression and immune evasion.

Main Results:

• Myeloid cells, particularly MDSCs, are key regulators of the GBM TME, often promoting tumor growth.
• The heterogeneity of GBM contributes to complex myeloid cell responses and immune suppression.
• Understanding these interactions is crucial for developing effective immunotherapies.

Conclusions:

• Myeloid cell populations critically influence Glioblastoma oncogenesis and progression.
• Targeting myeloid cell functions within the TME presents a promising avenue for novel GBM therapies.
• Further research into GBM-myeloid cell interactions can enhance treatment strategies and patient outcomes.